MBOT
Microbot Medical Inc
1.30$
-2.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.3% | -11.5% | +0.9% | -29.9% | +15.8% | +412.2% | +7.2% | +146.8% | -0.3% | -4.3% | -6.0% | |
| – | -5.8% | -11.6% | +2.0% | -30.0% | +16.5% | +426.8% | +7.3% | +145.6% | -1.2% | -4.1% | -5.7% | |
| – | +84.9% | -52.9% | +112.1% | -80.6% | +550.1% | +3.3% | +26.9% | +64.2% | -41.6% | -6.5% | -13.8% | |
| – | -21.7% | -0.6% | +1.8% | -32.9% | +26.1% | +455.6% | +7.5% | +145.3% | -2.0% | -7.8% | -7.1% | |
| – | – | – | – | – | – | – | – | – | – | -56.4% | +67.6% | |
| – | – | – | – | – | – | – | – | – | – | +286.5% | +28.8% | |
| – | +150.1% | -68.6% | +14.9% | +1.5% | +78.6% | -22.4% | +42.9% | +27.5% | +12.8% | -0.7% | +12.0% | |
| – | +153.9% | -68.8% | +13.4% | +2.2% | +79.4% | -23.0% | +44.1% | +7.6% | +16.6% | -1.0% | +14.8% | |
| – | -7.3% | +0.0% | -42.4% | -40.9% | +7.7% | +28.6% | +13.3% | +191.2% | -0.3% | +9.5% | +0.6% | |
| – | +50.0% | -73.1% | +85.4% | +38.2% | -32.9% | +12.7% | +170.4% | +1.2% | +0.4% | +112.3% | -19.7% | |
| – | -38.8% | +37.0% | -1.8% | -37.1% | -7.3% | +720.1% | +4.9% | +157.7% | -0.9% | -4.4% | -7.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.6% | +15.9% | +5.6% | +10.9% | +3.3% | +0.0% | +114.4% | +31.8% | +39.6% | +0.0% | +0.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.